Results Published Recommending Use of FerriScan in Sickle Cell Disease
- 10 November 2016
FerriScan has received further endorsement for the management of patients with Sickle Cell Disease (SCD) in apaper recently published by the highly respected Dr Janet Kwiatkowski team at the Children’s Hospital of Philadelphia, USA.
Resonance Health News - September 2016
- 30 September 2016
We are very pleased to provide an update of our most recent and upcoming activities. It has been a very productive quarter and we look forwards to further progressing our exciting new projects.
To view the newsletter please click here...
New FerriScan Video - A Clinician's Perspective
- 21 September 2016
We are delighted to present a short interview filmed between Resonance Health's Chief Scientific Officer, Prof. Tim St Pierre, and Dr Josu de la Fuente, a Consultant Paediatric Haematologist and Senior Lecturer at Imperial College London and Director of the Paediatric Blood and Marrow Transplant Programme. The video, filmed at the European Hematology Association (EHA) Congress 2016, discusses the clinical benefits of FerriScan.
Iron Monitoring in Cancer Survivors - Clinician Survey
- 09 September 2016
Iron Overload is increasingly recognised as a possible complication for cancer survivors who have received multiple blood transfusions during their cancer treatment. FerriScan can reliably and accurately screen for Iron Overload in cancer survivors with a history of blood transfusions, overcoming the poor sensitivity and specificity of serum ferritin and avoiding reliance on transfusion records, which can be incomplete.
Video Launch: "FerriScan - the Gold Standard in Liver Iron Measurement"
- 14 June 2016
Resonance Health proudly presents our new video "FerriScan - the Gold Standard in Liver Iron Measurement"....
Conference Showcase - April & May 2016
- 01 June 2016
RESONANCE HEALTH MAKING A DIFFERENCE
Our team has had a busy couple of months with attendance at seven key conferences, globally.